21-Aug-2026
Morgan Stanley Releases a Buy Rating on BioNTech SE (BNTX)
TipRanks (Mon, 24-Aug 8:15 AM ET)
BioNTech’s New HIV RNA Vaccine Trial: What Investors Should Watch Now
TipRanks (Fri, 21-Aug 12:33 PM ET)
Market Chameleon (Fri, 21-Aug 7:08 AM ET)
TipRanks (Thu, 20-Aug 8:55 AM ET)
BioNTech to Unveil Novel Lung Cancer Combination Data at WCLC 2026
TipRanks (Thu, 20-Aug 7:57 AM ET)
Analysts’ Opinions Are Mixed on These Healthcare Stocks: BioNTech SE (BNTX) and Centene (CNC)
TipRanks (Thu, 20-Aug 7:50 AM ET)
Market Chameleon (Thu, 20-Aug 3:10 AM ET)
Globe Newswire (Thu, 20-Aug 5:30 AM ET)
Analysts Offer Insights on Healthcare Companies: Xeris Pharmaceuticals (XERS) and BioNTech SE (BNTX)
TipRanks (Thu, 20-Aug 4:30 AM ET)
Biotechs hit a post-pandemic high after mRNA trial win for Moderna, Merck
Seeking Alpha News (Wed, 19-Aug 2:38 PM ET)
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
Biontech Se - American Depositary Shares trades on the NASDAQ stock market under the symbol BNTX.
As of August 21, 2026, BNTX stock price climbed to $116.57 with 2,755,175 million shares trading.
BNTX has a beta of 1.13, meaning it tends to be more sensitive to market movements. BNTX has a correlation of 0.09 to the broad based SPY ETF.
BNTX has a market cap of $29.48 billion. This is considered a Large Cap stock.
Last quarter Biontech Se - American Depositary Shares reported $123 million in Revenue and -$2.58 earnings per share. This fell short of revenue expectation by $-59 million and missed earnings estimates by -$.24.
In the last 3 years, BNTX traded as high as $131.49 and as low as $76.53.
The top ETF exchange traded funds that BNTX belongs to (by Net Assets): FBT, IBB, FNDF, SPDW, BBH.
BNTX has underperformed the market in the last year with a return of +5.2%, while SPY returned +21.7%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in BNTX shares. However, BNTX has outperformed the market in the last 3 month and 2 week periods, returning +28.2% and +24.4%, while SPY returned +3.4% and -1.0%, respectively. This indicates BNTX has been having a stronger performance recently.
BNTX support price is $108.03 and resistance is $113.76 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BNTX shares will trade within this expected range on the day.